Fludarabine and mitoxantrone for the refractory relapse treatment of B-cell low-grade non-Hodgkin lymphoma (NHL):: LACOHG first interim report (Latin American Cooperative Oncology Hematology Group).

被引：0

作者：

Baltazar-Arellano, Severiano

Pimentel, Patricia

Vera, Luis

Bezares, Fernando

Malaga, Jose

Huamani-Z, Julia

Montante, Antonio

Rivas-Vera, Silvia

Carrasco-Yalan, Antonio A.

Beltran-Garate, Brady E.

机构：

[1] Ctr Med Noreste, Monterrey, Mexico

[2] Hosp Edgardo Rebagliati Martins, Dept Hematol Oncol, Lima, Peru

[3] Hosp Alvarez, Dept Hematol, Buenos Aires, DF, Argentina

[4] Hosp Natl Del Sur, Dept Hematol, Arequipa, Peru

[5] Hosp Gen Mexico OD, Mexico City, DF, Mexico

[6] Inst Nacl Cancerol, Mexico City, DF, Mexico

来源：

BLOOD | 2006年 / 108卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4665

引用

页码：247B / 248B

页数：2

共 50 条

[31] A Case Report of Non-Hodgkin Low-grade B-cell Mucosa-associated Lymphoid Tissue Lymphoma Presenting as a Suspected Endodontic Lesion
Michaelson, Philip L.
Choi, Carl R.
Syriac, Susan
JOURNAL OF ENDODONTICS, 2021, 47 (01) : 140 - 145
[32] Improved Treatment Results of Children With B-Cell Non-Hodgkin Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 Study
Tsurusawa, Masahito
Mori, Tetsuya
Kikuchi, Akira
Mitsui, Tetsuo
Sunami, Shosuke
Kobayashi, Ryoji
Takimoto, Tetsuya
Saito, Akiko
Watanabe, Tomoyuki
Fujimoto, Junichiro
Nakazawa, Atsuko
Ohshima, Kouichi
Horibe, Keizo
PEDIATRIC BLOOD & CANCER, 2014, 61 (07) : 1215 - 1221
[33] A study of rituximab and ifosfamide, carboplatin, etoposide (ICE) chemotherapy in children with recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and mature B-cell acute lymphoblastic leukemia (B-ALL). A children's oncology group report
Griffin, T.
Weitzman, S.
Weinstein, H.
Chang, M.
Hutchison, R.
ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
[34] Treatment of B cell low grade non-Hodgkin's lymphoma (NHL) with anti-CD20 monoclonal antibody Rituximab®
Federico, M
Clo, V
Vinci, G
Sacchi, S
ANNALS OF ONCOLOGY, 1998, 9 : 32 - 32
[35] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
Kang, Hye Jin
Lee, Seung-Sook
Byun, Byung Hyun
Kim, Kyeong Min
Lim, Ilhan
Choi, Chang Woon
Suh, Cheolwon
Kim, Won Seog
Nam, Seung-Hyun
Lee, Soon Il
Eom, Hyeon Seok
Shin, Dong-Yeop
Lim, Sang Moo
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 945 - 953
[36] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
Hye Jin Kang
Seung-Sook Lee
Byung Hyun Byun
Kyeong Min Kim
Ilhan Lim
Chang Woon Choi
Cheolwon Suh
Won Seog Kim
Seung-Hyun Nam
Soon Il Lee
Hyeon Seok Eom
Dong-Yeop Shin
Sang Moo Lim
Cancer Chemotherapy and Pharmacology, 2013, 71 : 945 - 953
[37] AGGRESSIVE TREATMENT OF B-CELL NON-HODGKIN LYMPHOMA (NHL) - A PROTOCOL OF THE FRENCH PEDIATRIC ONCOLOGY SOCIETY - PRELIMINARY-RESULTS ON 60 PATIENTS
PATTE, C
BENZLEMOINE, E
PHILIP, T
DEMEOCQ, F
BERNARD, A
RODARY, C
LEMERLE, J
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (10): : 1052 - 1052
[38] Reduced-dose zevalin™ radioimmunotherapy for relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) patients with thrombocytopenia:: Report of interim results of a phase II trial.
Witzig, TE
White, CA
Gordon, LI
Schilder, RJ
Wiseman, GA
Rimmer, A
Parker, E
Grillo-Lopez, AJ
BLOOD, 1999, 94 (10) : 92A - 92A
[39] Multicener phase III study of iodine-131 tositumomab (anti-B1 antibody) for chemotherapy-refractory low-grade or transformed low-grade non-Hodgkin's lymphoma (NHL)
Kaminski, MS
Zelenetz, AD
Press, O
Saleh, M
Leonard, J
Fehrenbacher, L
Stagg, R
Kroll, S
Tidmarsh, G
Knox, S
Vose, J
BLOOD, 1998, 92 (10) : 316A - 316A
[40] Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia
Rasul, I
Shepherd, FA
Kamel-Reid, S
Krajden, M
Pantalony, D
Heathcote, EJ
HEPATOLOGY, 1999, 29 (02) : 543 - 547

← 1 2 3 4 5 →